These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28658514)

  • 1. The role and therapeutic potential of melatonin in age-related ocular diseases.
    Crooke A; Huete-Toral F; Colligris B; Pintor J
    J Pineal Res; 2017 Sep; 63(2):. PubMed ID: 28658514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin: Implications for Ocular Disease and Therapeutic Potential.
    Scuderi L; Davinelli S; Iodice CM; Bartollino S; Scapagnini G; Costagliola C; Scuderi G
    Curr Pharm Des; 2019; 25(39):4185-4191. PubMed ID: 31724508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress.
    Dehdashtian E; Mehrzadi S; Yousefi B; Hosseinzadeh A; Reiter RJ; Safa M; Ghaznavi H; Naseripour M
    Life Sci; 2018 Jan; 193():20-33. PubMed ID: 29203148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative Stress, Ocular Disease and Diabetes Retinopathy.
    Tangvarasittichai O; Tangvarasittichai S
    Curr Pharm Des; 2018; 24(40):4726-4741. PubMed ID: 30644339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential.
    Crooke A; Huete-Toral F; Martínez-Águila A; Colligris B; Pintor J
    Expert Opin Drug Discov; 2012 Oct; 7(10):989-1001. PubMed ID: 22860991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of melatonin in experimental free radical-related ocular diseases.
    Siu AW; Maldonado M; Sanchez-Hidalgo M; Tan DX; Reiter RJ
    J Pineal Res; 2006 Mar; 40(2):101-9. PubMed ID: 16441546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repertoires of autophagy in the pathogenesis of ocular diseases.
    Li YJ; Jiang Q; Cao GF; Yao J; Yan B
    Cell Physiol Biochem; 2015; 35(5):1663-76. PubMed ID: 25833234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin in the eye: implications for glaucoma.
    Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP; Rosenstein RE
    Exp Eye Res; 2007 Jun; 84(6):1021-30. PubMed ID: 17174303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-environment interactions in ocular diseases.
    Sacca SC; Bolognesi C; Battistella A; Bagnis A; Izzotti A
    Mutat Res; 2009 Jul; 667(1-2):98-117. PubMed ID: 19046976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of melatonin in the eye and ocular dysfunctions.
    Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP
    Vis Neurosci; 2006; 23(6):853-62. PubMed ID: 17266777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental light and endogenous antioxidants as the main determinants of non-cancer ocular diseases.
    Saccà SC; Roszkowska AM; Izzotti A
    Mutat Res; 2013; 752(2):153-171. PubMed ID: 23337404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin: Unveiling the functions and implications in ocular health.
    Zhang J; Zhou H; Cai Y; Yoshida S; Li Y; Zhou Y
    Pharmacol Res; 2024 Jul; 205():107253. PubMed ID: 38862072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aging and retinal vascular diseases].
    Takagi H
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy in the eye: Development, degeneration, and aging.
    Boya P; Esteban-Martínez L; Serrano-Puebla A; Gómez-Sintes R; Villarejo-Zori B
    Prog Retin Eye Res; 2016 Nov; 55():206-245. PubMed ID: 27566190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role and Therapeutic Potential of Melatonin in Degenerative Fundus Diseases: Diabetes Retinopathy and Age-Related Macular Degeneration.
    Ma C; Li H; Lu S; Li X
    Drug Des Devel Ther; 2024; 18():2329-2346. PubMed ID: 38911030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.
    Babizhayev MA
    Fundam Clin Pharmacol; 2012 Feb; 26(1):86-117. PubMed ID: 21883446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Density Lipoprotein Cholesterol in Age-Related Ocular Diseases.
    Betzler BK; Rim TH; Sabanayagam C; Cheung CMG; Cheng CY
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32331355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperbaric oxygen therapy and the possibility of ocular complications or contraindications.
    McMonnies CW
    Clin Exp Optom; 2015 Mar; 98(2):122-5. PubMed ID: 25308346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging and Vision.
    Alavi MV
    Adv Exp Med Biol; 2016; 854():393-9. PubMed ID: 26427437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and reactive oxygen species: a review of their role in ocular disease.
    Ung L; Pattamatta U; Carnt N; Wilkinson-Berka JL; Liew G; White AJR
    Clin Sci (Lond); 2017 Dec; 131(24):2865-2883. PubMed ID: 29203723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.